AtriCure (ATRC) Non-Current Assets (2010 - 2026)
AtriCure (ATRC) posted quarterly Non-Current Assets of $331.1 million for Q2 2026, down 1.92% year-over-year from $337.6 million in Q2 2025, and little changed quarter-over-quarter from $330.3 million in Q1 2026.
AtriCure (ATRC) Non-Current Assets (2010 - 2026) Analysis & Trends
AtriCure (ATRC) has reported Non-Current Assets for 17 consecutive years, with $331.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Non-Current Assets fell 1.92% year-over-year to $331.1 million; the TTM figure through Jun 2026 stood at $1.3 billion (down 2.76% YoY), while the FY2025 annual figure was $331.7 million, down 2.88% from the prior year.
- Non-Current Assets held at $331.1 million in Q2 2026 per ATRC's latest filing, from $330.3 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $385.4 million in Q1 2022 and bottomed at $330.3 million in Q1 2026.
- Historically, Non-Current Assets has averaged $349.2 million across 5 years, with a median of $345.3 million in 2023.
- Annual changes were most pronounced in 2022 — Non-Current Assets fell 18.04% — and 2024, when it climbed 0.47%.
- AtriCure's Non-Current Assets stood at $370.2 million in 2022, then retreated by 6.09% to $347.7 million in 2023, then decreased by 1.78% to $341.5 million in 2024, then decreased by 2.88% to $331.7 million in 2025, then declined by 0.17% to $331.1 million in 2026.
- Business Quant data shows ATRC's Non-Current Assets at $331.1 million in Q2 2026, $330.3 million in Q1 2026, and $331.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 11.33 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 42.59 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 24.47 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 4.64 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 27.61 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 10.50 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 10.18 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.80 Bn |
| 10 | AtriCure | 2.39 Bn | 2.22 Bn | 118.63 Mn | 331.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 331.11 Mn |
| Mar 31, 2026 | 330.30 Mn |
| Dec 31, 2025 | 331.66 Mn |
| Sep 30, 2025 | 334.33 Mn |
| Jun 30, 2025 | 337.59 Mn |
| Mar 31, 2025 | 340.15 Mn |
| Dec 31, 2024 | 341.50 Mn |
| Sep 30, 2024 | 345.78 Mn |
| Jun 30, 2024 | 344.42 Mn |
| Mar 31, 2024 | 346.40 Mn |
| Dec 31, 2023 | 347.69 Mn |
| Sep 30, 2023 | 347.55 Mn |
| Jun 30, 2023 | 356.20 Mn |
| Mar 31, 2023 | 344.78 Mn |
| Dec 31, 2022 | 370.23 Mn |
| Sep 30, 2022 | 369.63 Mn |
| Jun 30, 2022 | 381.22 Mn |
| Mar 31, 2022 | 385.38 Mn |
| Dec 31, 2021 | 419.24 Mn |
| Sep 30, 2021 | 417.26 Mn |